QuidelOrtho to Report Second Quarter 2025 Financial Results
QuidelOrtho (NASDAQ: QDEL), a global provider of in vitro diagnostic technologies, has scheduled its second quarter 2025 financial results announcement for Tuesday, August 5, 2025, after market close.
Rhea-AI Summary
QuidelOrtho (NASDAQ: QDEL), a global provider of in vitro diagnostic technologies, has scheduled its second quarter 2025 financial results announcement for Tuesday, August 5, 2025, after market close.
The company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss the results. Investors can access the webcast through QuidelOrtho's investor relations website, or join via phone using specific dial-in numbers. Presentation materials will be available on the company's website concurrent with the call.
Positive
- None.
Negative
- None.
Details
News Market Reaction – QDEL
The recorded move for QDEL in the trading session of this news was +4.15%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the call from the "Events & Presentations" section of the "Investor Relations" page of the Company's website at https://ir.quidelortho.com. Presentation materials will also be posted to the "Events & Presentations" section of the "Investor Relations" page of the Company's website at the time of the call. Those unable to access the webcast may join the call via phone by dialing 833-470-1428 (domestic) or +1 929-526-1599 (international) and entering Conference ID number 689337.
A replay of the conference call will be available shortly after the event on the "Investor Relations" page of the Company's website under the "Events & Presentations" section.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic.
Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@quidelortho.com
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@quidelortho.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-report-second-quarter-2025-financial-results-302511072.html
SOURCE QuidelOrtho Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.